The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A nationwide multicenter study in patients with unresectable hepatocellular carcinoma treated with lenvatinib in real world practice in Japan.
 
Kaoru Tsuchiya
Consulting or Advisory Role - Bayer; Eisai
Speakers' Bureau - Bayer; Eisai
 
Masayuki Kurosaki
Consulting or Advisory Role - Bayer; Eisai; Gilead Sciences
Speakers' Bureau - Bayer; Eisai; Gilead Sciences
 
Shun Kaneko
No Relationships to Disclose
 
Toru Kimura
No Relationships to Disclose
 
Hiroyuki Marusawa
No Relationships to Disclose
 
Hirotaka Arai
No Relationships to Disclose
 
Takehiko Abe
No Relationships to Disclose
 
Hiroyuki Kimura
No Relationships to Disclose
 
Keiji Tsuji
No Relationships to Disclose
 
Koichiro Furuta
No Relationships to Disclose
 
Chikara Ogawa
No Relationships to Disclose
 
Ryoichi Narita
No Relationships to Disclose
 
Yuji Kojima
No Relationships to Disclose
 
Takehiro Akahane
No Relationships to Disclose
 
Yasushi Uchida
No Relationships to Disclose
 
Hideo Yoshida
No Relationships to Disclose
 
Haruhiko Kobashi
No Relationships to Disclose
 
Atsunori Kusakabe
No Relationships to Disclose
 
Kouji Joko
No Relationships to Disclose
 
Namiki Izumi
Consulting or Advisory Role - Bayer; Chugai Pharma; Eisai; Otsuka
Speakers' Bureau - Bayer; Eisai; Gilead Sciences; Otsuka